Home
PB Ratio of Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd
NSE: AccretionPha.
PB Ratio
Key Highlights
- The latest PB Ratio of Accretion Pharmaceuticals Ltd is 2.2.
- The PB ratio of the Accretion Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The latest PB Ratio of Accretion Pharmaceuticals Ltd is 0.
- The PB ratio of the Accretion Pharmaceuticals Ltd is below 1 which indicates that the stock is undervalued.

Accretion Pharmaceuticals Ltd
NSE: AccretionPha.
PB Ratio
Company Fundamentals for Accretion Pharmaceuticals Ltd
Market Price of Accretion Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
23 May 2025 | 74.9 |
22 May 2025 | 78.8 |
21 May 2025 | 82.95 |
SWOT Analysis
BlinkX Score for Accretion Pharmaceuticals Ltd
Asset Value vs Market Value of Accretion Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Key Valuation Metric of Accretion Pharmaceuticals Ltd
₹
₹
X
Historical Market Cap of Accretion Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Accretion Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Accretion Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Accretion Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Accretion Pharmaceuticals Ltd News Hub
NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times
The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as
Read more
19 May 25
NSE SME Accretion Pharma stumbles on market debut
The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stoc
Read more
21 May 25